GENTAUR Contact Gentaur

Up
AngioKit protocols

GENTAUR Survey

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
Fax 0032 16 50 90 45
info@gentaur.com

GENTAUR Ltd. GB111298832
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com
Natwest bank Whetstone
Account no. 82577846 sort code 602336

GENTAUR France SARL FR63484237888
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50
Fax 01 43 25 01 60
RCS Paris B 484 237 888
SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com

GENTAUR GmbH
DE815175831
Marienbongard 20
52062 Aachen Deutschland
Tel tech support 0241 56 00 99 68  Frau Karolina Eland
de@gentaur.com
or  Tel 0241 95 78 94 78 Mr Tryan Ilkov
Tel logistics 0241 40 08 90 86 Annick Verdeyen
Fax 0241 55  91 05 36
Bankleitzahl 39050000
IBAN DE8839050000107569353
Handelsregister Aachen HR B 16058
Steuernummer 201/5961/3925
de@gentaur.com

GENTAUR Nederland BV NL850396268B01
Kuiper 1
5521 DG Eersel Nederland
KVK nummer 52327027
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U

GENTAUR Poland Sp. z o.o. PL2040002710
Ulica Ogarna 15/19B m2
80-826 GDANSK Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              
(TEL production Warsaw 0223 98 82 21)
poland@gentaur.com

GENTAUR USA
Genprice Inc.
Tel (408)350 0488
Tel (718)513-2983 before 9 a.m. for shipping questions
Fax (408)748-1826
3333 Bowers Avenue, Suite 130
Santa Clara, CA 95054
sales@genprice.com

GENTAUR Italy
20135 Milano
Tel 02 36 00 65 93 Fax 02 36 00 65 94
italia@gentaur.com

GENTAUR Spain
tel:0911876558
spain@gentaur.com

GENTAUR BULGARIA BG201358931
53, Graf Ignatiev Str. ent.V, fl. 2
Sofia 1000
Tel 0035929830070
Fax 0035929830072
sofia@gentaur.com

ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035929830070 Fax 0035929830072
e-mail: Sofia@gentaur.com
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

Other countries
Österreich +43720880899
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Danmark +4569918806
Finland Helsset +358942419041
Magyarország Budapest +3619980547
Ireland Dublin+35316526556
Luxembourg+35220880274
Norge Oslo+4721031366
Sverige Stockholm+46852503438
Schweiz Züri+41435006251
US New York+17185132983

 

Publications citing use of the TCS human cell angiogenesis model. Update October 2004

 1.      Grohmann, M et al, (1999)

‘Nitric oxide released via VEGFR-1 suppresses VEGFR-2 mediated endothelial cell growth and regulates angiogenesis’

J. Reprod. Fertil. (Abs Series 24) No 48

 2.      Brooks, T.D. et al, (1999)

‘Antibodies to PAI-1 suppress angiogenesis in vitro

Clin. Exp. Metastasis 17 (9); 112  

3.      Bishop, E.T. et al, (2000)

‘An in vitro model of angiogenesis: Basic features

Angiogenesis 3; (4); 335-344 

4.      Bryant,  et al , (2000)

‘Tissue repair with a therapeutic transcription factor’

Human Gene Therapy 11; 2143-2158

 5.      Donovan et al, (2001)

‘Comparison of three in vitro human ‘angiogenesis’ assays with capillaries formed in vivo

Angiogenesis 4; 113-121

 

6.      Frandsen, T. et al,  Clin. Cancer Res. 7; Suppl. (2001)

 

7.      Bussolati, B. et al, (2001)

‘Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide’

Am. J. Path. 159; 993-1008

 8.      Houston, P. et al, (2001)

‘The transcriptional co-repressor NAB2 blocks Egr-1-mediated growth factor activation and angiogenesis’

Biochem. Biophys. Res. Commun. 283; 480-486

 9.      Murphy, J.E. & Fitzgerald, D.J., (2001)

‘Vascular endothelial growth factor induces cyclooxygenase-dependent proliferation of endothelial cells via the VEGF-2 receptor’.

FASEB J. 15; 1667-1

 10.  Jia, H. et al, (2001)

‘Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF’

Biochem. Biophys. Res. Commun. 283; 164-173

 

11.  Ohno-Matsui, K. et al, (2001)

'Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF'

J. Cell. Physiol. 189; 323-333

  

12.  Terai, Y. et al, (2001)

'Vascular smooth muscle cell growth promoting factor / F-spondin inhibits angiogenesis via the blockade of integrin aVb3 on vascular endothelial cells.

J. Cell. Physiol. 188; 394-402 

13.  Harmey, J.H. et al, (2002)

'Lipoylsaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumour invasion'

Int. J. Cancer 101; 415-422  

14.  Iba, O. et al, (2002)

"Angiogenesis by implantation of peripheral blood mononuclear cells into ischaemic limbs"

Circulation 106: 2019 

15.  Rossig, L., et al, (2002)

"Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation & angiogenesis"

Circulation Research 91, 837-851 

16.  Gliki, G. et al, (2002)

‘Vascular endothelial growth factor induces protein kinase c (PKC)-dependent Akt/PKB activation and phosphatidylinositol 3’-kinase-mediated PKCd phosphorylation: Role of PKC in angiogenesis’

Cell Biology International 26; 751-759  

17.  Brooks, T. et al,  Proc. AACR 43; 137 (2002) 

18.  Drinkwater, S.L., et al, (2002)

‘Effect of venous ulcer exudates on angiogenesis in vitro’

Brit. J. Surg. 89; 709-713 

19.  Urbich, C. et al. (2002)

'Dephosphorylation of endothelial nitric oxide synthase contributes to the

anti-angiogeneic effects of endostatin'.

FASEB J. express article 10.1096/fj.01-0637fje. 

20.  Urbich, C. et al. (2002)

'Double-Edged Role of Statins in Angiogenesis Signalling'

Circulation Research. 90: 737-744. 

21.  Osugi, T. et al (2002)

'Cardiac-specific activation of Signal Transducer and Activator of Transcription-3 promotes vascular formation in the heart'

J. Biol. Chem. 227; 6676-6681 

22.  Kronenwett, R. et al, (2002)

'Inhibition of angiogenesis in vitro by aV integrin-directed antisense oligonucleotides'.

Cancer Gene Therapy 9; 587-596 

23.  Dredge, K. et al (2002)

'Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects'.

Brit. J. Cancer 87; 1166-1172 

24.   Urbich et al (2002)

'CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species'

Circulation, 106; 981-986 

25.  Svensson, L.A. et al (2002)

'The cytolethal distending toxin of Haemophilus ducreyi inhibits endothelial cell proliferation'

Infection & Immunity 70; 2665-2669 

26.  Sengupta, S. et al (2003)

'Thymidine phosphorylase induces angiogenesis in vivo and in vitro: an evaluation of possible mechanisms'

Brit. J. Pharmacol. In Press 

27.  Oshima, Y. et al, (2003)

'Expression and localisation of tenomodulin, a transmembrane type chondomodulin-I-related angiogenesis inhibitor, in mouse eyes'.

Invest. Ophthalmol. Vis. Sci. 44; 1814-1823 

28.  Igagarishi, T. et al (2003)

'Lentivirus-mediated expression of angiostatin efficiently inhibits neovascularisation in a murine proliferative retinopathy model'.

Gene Therapy 10; 219-226 

29.  Shalhoub, J. et al, (2003)

'Anti-angiogenic activity of heparins and antithrombin

J. Thromb. Haemostasis 1 Suppl July, P0846  

30.  Burns, P.A. & Wilson, D.J., (2003)

'Angiogenesis mediated by metabolites is dependent on VEGF'

Angiogenesis 6; 23-77 

31.  Duval, H. et al, (2003)

'New insights into the function and regulation of endothelial cell apoptosis'

Angiogenesis  6; 171-183 

32.  Cai, J. et al, (2003)

'Activation of VEGF-R1 sustains angiogenesis and Bcl-2 expression via the PI3-kinase pathway in endothelial cells'

Diabetes 52; 2951-2968 

33.  Patel et al, (2004)

'Enhanced angiogenesis following allogeneic blood transfusion'

Clin. Lab. Haematol. 26; 129-134  

34.  Zhang, W. et al, (2004)

'Effects of insulin-like growth factor-binding proteins 1 through 5 on in vitro angiogenesis assay'

Proc. AACR 45; 4341 March 2004  

35.  Newman, S. et al,  (2004)

'Inhibition of in vitro angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamates'

Int. J. Cancer 109; 533-540 

36.  Campioni, D. et al, (2004)

'In vitro evaluation of bone marrow angiogenesis in myelodysplastic syndromes: a morphological and functional approach'.

Leuk. Res. 28; 9-17   

37.  Kumar, S. et al, (2004)

'Bone marrow angiogenic ability and expression of angiogenic cytokines in melamoma: Evidence favouring loss of marrow angiogenesis inhibitory activity with disease progression'

Blood 104: 1159-1165  

38.  Print, C. et al, (2004)

'Soluble factors from human endometrium promote angiogenesis and regulate the endothelial cell transcriptome'

Hum. Reprod. 19; 2356-2366 

 

TCS AngioKit:  CD31 stained tubule formation


 

Home ] Up ] AngioKit protocols ]

Send mail to webmaster@gentaur.com with questions or comments about this web site.
Copyright © 2008 Gentaur Molecular Products
Site powered by Acid Dragon (AC)
Last modified: 07/15/09